Literature DB >> 23905577

Combinational delivery of lipid-enveloped polymeric nanoparticles carrying different peptides for anti-tumor immunotherapy.

Songwei Tan1, Tetsuro Sasada, Anna Bershteyn, Kunyu Yang, Tetsuya Ioji, Zhiping Zhang.   

Abstract

AIM: The authors aimed to investigate whether nanotechnology-based delivery of antigenic peptides is feasible for efficiently inducing anti-tumor cytotoxic T lymphocyte responses through vaccination. MATERIALS &
METHODS: Three different murine melanoma antigens were entrapped in lipid-coated poly(D,L-lactide-co-glycolide) nanoparticles (NPs) by the double emulsion method.
RESULTS: The loading efficiency of hydrophilic peptides was greatly improved when lipids were introduced to formulate lipid-coated NPs. The lipid-coated NPs carrying a single peptide and/or combinations of multiple lipid-coated NPs carrying antigenic peptides were characterized in vitro and in vivo in a C57/BL6 (B6) mouse model. Both the single melanoma antigen peptide-loaded NPs and combinational delivery of lipid-coated NPs carrying different peptides could induce antigen-specific T-cell responses. However, single peptide-loaded NPs failed to significantly delay the growth of subcutaneously inoculated B16 melanoma cells in a prophylactic setting. By contrast, the combinational delivery of lipid-coated NPs carrying different peptides significantly suppressed growth of inoculated B16 melanoma cells.

Entities:  

Keywords:  T-cell responses; cancer; immunotherapy; lipid-coated nanoparticle; melanoma; vaccine antigens

Mesh:

Substances:

Year:  2013        PMID: 23905577     DOI: 10.2217/nnm.13.67

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  6 in total

Review 1.  Nanovaccines for cancer immunotherapy.

Authors:  Yu Zhang; Shuibin Lin; Xiang-Yang Wang; Guizhi Zhu
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2019-06-06

Review 2.  Biomaterials for nanoparticle vaccine delivery systems.

Authors:  Preety Sahdev; Lukasz J Ochyl; James J Moon
Journal:  Pharm Res       Date:  2014-05-22       Impact factor: 4.200

3.  α-Galactosylceramide and peptide-based nano-vaccine synergistically induced a strong tumor suppressive effect in melanoma.

Authors:  Vanessa Sainz; Liane I F Moura; Carina Peres; Ana I Matos; Ana S Viana; Angela M Wagner; Julia E Vela Ramirez; Teresa S Barata; Manuela Gaspar; Steve Brocchini; Mire Zloh; Nicholas A Peppas; Ronit Satchi-Fainaro; Helena F Florindo
Journal:  Acta Biomater       Date:  2018-06-22       Impact factor: 8.947

4.  Co-delivery of human cancer-testis antigens with adjuvant in protein nanoparticles induces higher cell-mediated immune responses.

Authors:  Medea Neek; Jo Anne Tucker; Tae Il Kim; Nicholas M Molino; Edward L Nelson; Szu-Wen Wang
Journal:  Biomaterials       Date:  2017-11-20       Impact factor: 12.479

Review 5.  Nanoimmunoengineering strategies in cancer diagnosis and therapy.

Authors:  Robabehbeygom Ghafelehbashi; Melina Farshbafnadi; Niloofar Shokraneh Aghdam; Shahin Amiri; Mitra Salehi; Sepideh Razi
Journal:  Clin Transl Oncol       Date:  2022-09-08       Impact factor: 3.340

Review 6.  Nanoparticle-Based Manipulation of Antigen-Presenting Cells for Cancer Immunotherapy.

Authors:  Ronnie H Fang; Ashley V Kroll; Liangfang Zhang
Journal:  Small       Date:  2015-09-02       Impact factor: 13.281

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.